A First for Cyprus: EMBIO Diagnostics Secures EU Funding to Develop RapidX
EMBIO Diagnostics has reached an important milestone for both the company and Cyprus’ innovation ecosystem, becoming the first Cypriot company...
Read moreEMBIO Diagnostics has reached an important milestone for both the company and Cyprus’ innovation ecosystem, becoming the first Cypriot company...
Read moreValencia, March 2nd, 2026 Twenty-four European companies will receive €2.4 million in funding after being selected in the first Open Call of...
Read moreOn February 4, air pollution was officially recognized as a cancer risk factor in Europe, following its inclusion in the 5th edition of the...
Read moreEMBIO Diagnostics was honoured to welcome distinguished guests from Nanjing University, one of the world’s leading technology universities, as...
Read moreRecognizing the significant opportunities emerging in the region, EMBIO Diagnostics CEO Constantinos Loizou attended CyprusForumAthens 2025. He...
Read more